Form 4 holding
Chief Executive Officer, Director
Outlook Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 151,515
- Estimated value
- $240,908
- Report date
- 14 Aug 2026
- Price
- $1.59
- Ownership
- Direct
Robert Charles Jahr - Chief Executive Officer, Director at Outlook Therapeutics, Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- OTLK on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert Charles Jahr since 03 Sep 2025
Reported holdings for Robert Charles Jahr in Outlook Therapeutics, Inc.
Form 4 holding
Chief Executive Officer, Director
Outlook Therapeutics, Inc.
- Security class
- Warrants (right to buy)
- Shares / value
- 151,515
- Estimated value
- Report date
- 14 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Outlook Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 100,000
- Estimated value
- Report date
- 21 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert Charles Jahr in Outlook Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.